scispace - formally typeset
M

Marieke D. Spreeuwenberg

Researcher at Public Health Research Institute

Publications -  121
Citations -  5140

Marieke D. Spreeuwenberg is an academic researcher from Public Health Research Institute. The author has contributed to research in topics: Health care & Referral. The author has an hindex of 36, co-authored 117 publications receiving 4563 citations. Previous affiliations of Marieke D. Spreeuwenberg include Maastricht University & VU University Medical Center.

Papers
More filters
Journal ArticleDOI

Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

TL;DR: The RV contains prognostic information in IPAH and a large RV volume, low SV, and a reduced LV volume are strong independent predictors of mortality and treatment failure.
Journal ArticleDOI

Predicting ADL disability in community-dwelling elderly people using physical frailty indicators: a systematic review

TL;DR: It is indicated that individual physical frailty indicators, such as weight loss, gait speed, grip strength, physical activity, balance, and lower extremity function are predictors of future ADL disability in community-dwelling elderly people.
Journal ArticleDOI

Right coronary artery flow impairment in patients with pulmonary hypertension

TL;DR: Although in controls, RCA flow is similar in systole and diastole, in PH there is systolic flow impediment, which is proportional to RV pressure and mass, and in patients with severe RV hypertrophy total mean flow is reduced.
Journal ArticleDOI

Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.

TL;DR: In high-risk patients with BS, primary prophylactic ICD therapy is an effective treatment and the IS rate is high, suggesting a trend towards shorter appropriate shock-free survival.
Journal ArticleDOI

Oral Nutritional Supplements Containing (n-3) Polyunsaturated Fatty Acids Affect the Nutritional Status of Patients with Stage III Non-Small Cell Lung Cancer during Multimodality Treatment

TL;DR: In conclusion, a protein- and energy-dense oral nutritional supplement containing (n-3) fatty acids beneficially affects nutritional status during multimodality treatment in patients with NSCLC.